Rheumatology Advance Access originally published online on February 16, 2005
Rheumatology 2005 44(5):684-685; doi:10.1093/rheumatology/keh570
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
LETTER TO THE EDITOR |
Corneodesmosin polymorphisms in psoriatic arthritis
St Clare's Mercy Hospital, Memorial University of Newfoundland, St John's, Newfoundland, 1 Center for Prognosis Studies in Rheumatic Diseases, University Health Network, University of Toronto, Toronto, Canada and 2 MRC Biostatistics Unit, Institute of Public Health, Cambridge, UK
Correspondence to: P. Rahman, St Clare's Mercy Hospital, 1 South, 154 LeMarchant Rd, St John's, Newfoundland, Canada A1C 5B8. E-mail: prahman@mun.ca
| The first 10% of the full text of this article appears below. |
SIR, Based on association studies and genome-wide linkage scans in psoriasis, there is convincing evidence for a major psoriasis susceptibility locus within the MHC complex (reviewed in [1]). The primary area of interest resides in a 200 kb region between HLA-C and corneodesmosin (CDSN) that is in strong linkage disequilibrium (LD). Despite widely reported associations between HLA-Cw0602 and psoriasis, there is ongoing debate about the